PRESSR: Cleveland Clinic Abu Dhabi's multidisciplinary team successfully performs heart transplant

First published: 10-May-2024 15:21:17

Series of challenging interventions is a testament to Cleveland Clinic Abu Dhabi’s world-class complex care, and the success of its multidisciplinary approach

The hospital has multi-organ transplant center, and is a Centre of Excellence for adult cardiac surgery

Abu Dhabi, United Arab Emirates: Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully completed a complex heart transplant for Muhammad Al Ketbi   suffering from familial cardiomyopathy. The 28-year-old Emirati patient, who had been suffering with heart disease for more than a decade, developed multi-organ failure, and was initially placed on an Extracorporeal membrane oxygenation (an external pump for their heart).

Muhammad later needed to be placed on two separate pumps, one for the right and one for the left side of the heart, known as a biventricular assist device (BiVAD). For four months, he was on a BiVAD to stabilize his condition while awaiting a suitable donor for a heart transplant. This landmark case is the first in the UAE where the patient has successfully undergone these three sequential stages of treatment.

Muhammad was first transferred to Cleveland Clinic Abu Dhabi in a state of cardiogenic shock. Following a thorough assessment, the medical team found debilitating fluid accumulation in his lungs and abdomen. The multidisciplinary team of physicians intervened immediately to drain the fluid in his abdomen, which resulted in an improvement in his breathing.

Explaining the complexity of the case, Dr. Nadya Almatrooshi, Staff Physician for cardiology in advanced heart failure and transplant within the Heart, Vascular & Thoracic Institute at Cleveland Clinic Abu Dhabi said, “When Muhammad came to us, his condition was very severe. He could not even lie down comfortably and was having severe difficulty breathing. We learnt from his previous care team that Muhammad had stopped responding to medication. He was therefore admitted to the Intensive Care Unit (ICU) at Cleveland Clinic Abu Dhabi for close monitoring. However, his condition continued to deteriorate, affecting his liver and kidneys.”

It was clear that a heart transplant was imminent, but with multi-organ failure, Muhammad’s condition was unstable He was placed on extracorporeal membrane oxygenation (ECMO) support, which provided cardiac and respiratory assistance.

“In order to prepare Muhammad for the transplant, we had to improve his strength and overall condition. Our multidisciplinary team of physicians determined that installing a BiVAD, two implantable pumps that ensure blood circulation, would help reverse his kidney and liver failure, and present the best chance to help Muhammad as he awaited a suitable donor heart,” explained Dr. Mitesh Badiwala, Staff Physician for cardiothoracic surgery in the Heart, Vascular & Thoracic Institute of Cleveland Clinic Abu Dhabi.

Muhammad remained in the ICU on BiVAD, where his condition improved with nutrition and physical therapy, in time for surgery, when a heart compatible with his age and weight was found.

Dr. Feras Bader the Section Head for Heart Failure and Transplantation in the Heart, Vascular & Thoracic Institute of Cleveland Clinic Abu Dhabi said, “During this challenging procedure, the BiVAD was removed, and the donor heart was transplanted. The entire process took approximately six hours and was carried out smoothly with the support of our experts from various subspecialties, including cardiothoracic surgery, anesthesia, cardiac intensive care, nursing, pharmacy, and other areas to provide world-class care.”

“Muhammad's case exemplifies how Cleveland Clinic Abu Dhabi can tackle the most complex cardiac cases through a coordinated effort across specialties. The successful heart transplant and ultimately Muhammad’s return to full health is a testament to the knowledge and dedication of our multidisciplinary team at the Heart, Vascular & Thoracic Institute," added Dr. Bader.

Five days after the procedure, Muhammad’s condition improved and was moved out of the ICU to a cardiology ward. It was there that his care team explained the need to adhere to a regimen of immunosuppressants to ensure that his body did not reject the transplanted heart. A week later, Muhammad was finally discharged with advice to follow up regularly with Cleveland Clinic Abu Dhabi’s Transplant Center.

Muhammad, who is now living a normal life, expressed immense gratitude to his caregivers, “My family and I are extremely grateful for the high standards of care I received at Cleveland Clinic Abu Dhabi, which has been made possible through the vision of our wise leadership. It was a tremendous blessing to be able to undergo a heart transplant so close to home, surrounded by my family and friends. I am also thankful to my medical team, who monitored my health and well-being closely during a four-month stay at the ICU, and then gave me a new lease on life with a heart transplant.”

Muhammad’s story of a return to health is a reaffirmation of Cleveland Clinic Abu Dhabi’s personalized approach to care, which is enhanced with the use of cutting-edge technologies. The hospital houses the only multi-organ transplant center in the UAE and has also been designated by the Department of Health – Abu Dhabi as a Centre of Excellence (COE) for adult cardiac surgery.

To learn more about Cleveland Clinic Abu Dhabi’s Heart, Vascular & Thoracic Institute visit, https://www.clevelandclinicabudhabi.ae/en/institutes-and-specialties/heart-vascular-and-thoracic-institute

For more information on Cleveland Clinic Abu Dhabi’s Transplant Center visit, https://www.clevelandclinicabudhabi.ae/en/institutes-and-specialties/transplant-center 

To book an appointment at Cleveland Clinic Abu Dhabi, call 800 8 CCAD (2223) visit www.clevelandclinicabudhabi.ae  or download the Cleveland Clinic Abu Dhabi Patient Portal App.

About Cleveland Clinic Abu Dhabi

Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic’s model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population.

Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are offered at Cleveland Clinic Abu Dhabi.

The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world- class facilities across 24 clinical departments that include a range of cancer subspecialties and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others.

Cleveland Clinic Abu Dhabi provides patients in the region with direct access to the world’s best healthcare providers and Cleveland Clinic’s unique model of care that includes state-of-the-art amenities and world- class service standards closer to home.

M42 is a global tech-enabled health company, head-quartered in Abu Dhabi, operating at the forefront of medical   advancement.

Visit us at www.clevelandclinicabudhabi.ae

Media Contact

Email: mfarah@webershandwick.com

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.